Comparison of single-dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache

M. J. Belgrade; L. J. Ling; M. B. Schleevogt; M. G. Ettinger; E. Ruiz

doi:10.1212/wnl.39.4.590

Comparison of single-dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache

M. J. Belgrade, L. J. Ling, M. B. Schleevogt, M. G. Ettinger, E. Ruiz

Emergency Medicine

Research output: Contribution to journal › Article › peer-review

59 Scopus citations

Abstract

We treated 64 emergency room patients with a primary vascular headache with dihydroergotamine (DHE), meperidine, or butorphanol. Post-treatment pain scores were lowest in the DHE group (p < 0.01). Eight of 21 patients receiving DHE had greater than 90% reduction in pain compared with three of 19 patients receiving butorphanol and none of 22 receiving meperidine.

Original language	English (US)
Pages (from-to)	590-592
Number of pages	3
Journal	Neurology
Volume	39
Issue number	4
DOIs	https://doi.org/10.1212/wnl.39.4.590
State	Published - Apr 1989

Access

10.1212/wnl.39.4.590

OpenUrl availability

Full text

Cite this

@article{e20b5ae0a4b64251a9b1bde12d0e3b43,

title = "Comparison of single-dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache",

abstract = "We treated 64 emergency room patients with a primary vascular headache with dihydroergotamine (DHE), meperidine, or butorphanol. Post-treatment pain scores were lowest in the DHE group (p < 0.01). Eight of 21 patients receiving DHE had greater than 90% reduction in pain compared with three of 19 patients receiving butorphanol and none of 22 receiving meperidine.",

author = "Belgrade, {M. J.} and Ling, {L. J.} and Schleevogt, {M. B.} and Ettinger, {M. G.} and E. Ruiz",

year = "1989",

month = apr,

doi = "10.1212/wnl.39.4.590",

language = "English (US)",

volume = "39",

pages = "590--592",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "4",

}

TY - JOUR

T1 - Comparison of single-dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache

AU - Belgrade, M. J.

AU - Ling, L. J.

AU - Schleevogt, M. B.

AU - Ettinger, M. G.

AU - Ruiz, E.

PY - 1989/4

Y1 - 1989/4

N2 - We treated 64 emergency room patients with a primary vascular headache with dihydroergotamine (DHE), meperidine, or butorphanol. Post-treatment pain scores were lowest in the DHE group (p < 0.01). Eight of 21 patients receiving DHE had greater than 90% reduction in pain compared with three of 19 patients receiving butorphanol and none of 22 receiving meperidine.

AB - We treated 64 emergency room patients with a primary vascular headache with dihydroergotamine (DHE), meperidine, or butorphanol. Post-treatment pain scores were lowest in the DHE group (p < 0.01). Eight of 21 patients receiving DHE had greater than 90% reduction in pain compared with three of 19 patients receiving butorphanol and none of 22 receiving meperidine.

UR - http://www.scopus.com/inward/record.url?scp=0024550853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024550853&partnerID=8YFLogxK

U2 - 10.1212/wnl.39.4.590

DO - 10.1212/wnl.39.4.590

M3 - Article

C2 - 2648190

AN - SCOPUS:0024550853

SN - 0028-3878

VL - 39

SP - 590

EP - 592

JO - Neurology

JF - Neurology

IS - 4

ER -

Comparison of single-dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache

Abstract

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this